195 related articles for article (PubMed ID: 33461233)
1. Outcomes of Transsphenoidal Microsurgery for Prolactinomas - A Contemporary Series of 162 Cases.
Giese S; Nasi-Kordhishti I; Honegger J
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):163-171. PubMed ID: 33461233
[TBL] [Abstract][Full Text] [Related]
2. Operative treatment of cystic prolactinomas: a retrospective study.
Su W; He K; Yang Y; Xu J; Li X; Tang H; Yang J; Yang L
BMC Endocr Disord; 2023 May; 23(1):99. PubMed ID: 37143054
[TBL] [Abstract][Full Text] [Related]
3. SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP.
Donegan D; Atkinson JL; Jentoft M; Natt N; Nippoldt TB; Erickson B; Meyer F; Erickson D
Endocr Pract; 2017 Jan; 23(1):37-45. PubMed ID: 27682355
[TBL] [Abstract][Full Text] [Related]
4. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
[TBL] [Abstract][Full Text] [Related]
5. Surgery for prolactinomas: a better choice?
Honegger J; Nasi-Kordhishti I; Aboutaha N; Giese S
Pituitary; 2020 Feb; 23(1):45-51. PubMed ID: 31853793
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous cerebrospinal fluid rhinorrhea in untreated macroprolactinoma--an indication for primary surgical therapy.
Honegger JB; Psaras T; Petrick M; Beuschlein F; Reincke M
Zentralbl Neurochir; 2006 Aug; 67(3):149-54. PubMed ID: 16958013
[TBL] [Abstract][Full Text] [Related]
8. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients.
Kreutzer J; Buslei R; Wallaschofski H; Hofmann B; Nimsky C; Fahlbusch R; Buchfelder M
Eur J Endocrinol; 2008 Jan; 158(1):11-8. PubMed ID: 18166812
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of transsphenoidal surgery in dopamine agonist-resistant prolactinomas: a retrospective study.
Wei L; Wei X
Hormones (Athens); 2021 Dec; 20(4):745-752. PubMed ID: 34275094
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery.
Han YL; Chen DM; Zhang C; Pan M; Yang XP; Wu YG
Medicine (Baltimore); 2018 Nov; 97(45):e13198. PubMed ID: 30407358
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome of Microscopic Transsphenoidal Surgery for Prolactinomas as an Alternative to Dopamine Agonists.
Park K; Park KH; Park HR; Lee JM; Kim YH; Kim DY; Won TB; Kong SH; Kim JH; Shin CS; Paek SH
J Korean Med Sci; 2021 Apr; 36(15):e97. PubMed ID: 33876586
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of prolactinomas: cons.
Bloomgarden E; Molitch ME
Endocrine; 2014 Dec; 47(3):730-3. PubMed ID: 25112227
[TBL] [Abstract][Full Text] [Related]
13. First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.
Andereggen L; Frey J; Andres RH; Luedi MM; El-Koussy M; Widmer HR; Beck J; Mariani L; Seiler RW; Christ E
J Endocrinol Invest; 2021 Dec; 44(12):2621-2633. PubMed ID: 33847973
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States.
Jethwa PR; Patel TD; Hajart AF; Eloy JA; Couldwell WT; Liu JK
World Neurosurg; 2016 Mar; 87():65-76. PubMed ID: 26548828
[TBL] [Abstract][Full Text] [Related]
15. Current indications for the surgical treatment of prolactinomas.
Smith TR; Hulou MM; Huang KT; Gokoglu A; Cote DJ; Woodmansee WW; Laws ER
J Clin Neurosci; 2015 Nov; 22(11):1785-91. PubMed ID: 26277642
[TBL] [Abstract][Full Text] [Related]
16. Surgical management considerations in cystic prolactinomas-a single center case series.
Nevzati E; Chatain GP; Carr SB; Lillehei KO; Kerr JM
Endocrine; 2020 Jan; 67(1):58-66. PubMed ID: 31773633
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Endoscopic Transsphenoidal Resection for Prolactinoma: A Retrospective Multicenter Case-series.
Zandbergen IM; Huntoon KM; White TG; Bakker LEH; Verstegen MJT; Ghalib LM; van Furth WR; Pelsma ICM; Dehdashti AR; Biermasz NR; Prevedello DM
Arch Med Res; 2023 Dec; 54(8):102919. PubMed ID: 38040527
[TBL] [Abstract][Full Text] [Related]
18. Giant prolactinomas: clinical management and long-term follow up.
Shrivastava RK; Arginteanu MS; King WA; Post KD
J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
[TBL] [Abstract][Full Text] [Related]
19. [Cerebrospinal fluid rhinorrhea in primary treatment of large and giant prolactinomas with dopamine agonists].
Kalinin PL; Shkarubo AN; Astafieva LI; Chernov IV; Ismailov DB; Kadashev BA; Fomichev DV; Kutin MA; Sharipov OI; Andreev DN; Fomochkina LA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(6):32-39. PubMed ID: 29393284
[TBL] [Abstract][Full Text] [Related]
20. Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.
D'Haens J; Van Rompaey K; Stadnik T; Haentjens P; Poppe K; Velkeniers B
Surg Neurol; 2009 Oct; 72(4):336-40. PubMed ID: 19604551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]